Why should I get asthma blood testing?

It clarifies what kind of inflammation is driving your asthma. Higher blood eosinophils point to eosinophilic/type 2 asthma and greater flare risk; CRP shows if there is broader systemic inflammation that may worsen control. With Superpower, eosinophils and CRP help you and your clinician link biology to symptoms, predict exacerbation risk, and monitor whether treatment is reducing inflammation.

Can I get a blood test at home?

Yes. With Superpower, our team member can organise a blood draw in your home.

How often should I test?

Start with a baseline. Recheck when symptoms change, after major treatment changes, or around exacerbations to see how inflammation shifts. If you have eosinophilic features or frequent flares, periodic monitoring (for example, once or twice a year) can help track stability. Routine testing is otherwise occasional and guided by your clinical picture.

Are there any preparations needed before the blood test for eosinophils, CRP?

No fasting is required. Avoid unusually strenuous exercise right before the draw, as it can transiently shift white cell counts and CRP. If you’re on steroids or biologics, the timing of your dose can influence eosinophils; note dose timing when testing. Testing during a flare versus when well will show different biology, so context matters.

Can lifestyle changes affect my biomarker levels?

Yes. Factors that reduce whole‑body inflammation tend to lower CRP, and factors that reduce allergic/type 2 airway activation tend to lower eosinophils. Body weight, smoking exposure, sleep quality, infection burden, and allergen exposure all influence these pathways. The biomarkers reflect the inflammatory state across systems; when that state shifts, the numbers follow.

Asthma: Inflammatory Biomarkers and Airway Signals

Creator: Superpower
Published: 2025-11-06

Understand what your immune health results really mean

See your biomarkers in context with a comprehensive panel.

CLIA-certified labs
HIPAA compliant
Personalized health protocol

Book your test

Asthma and the inflammatory signals behind it

Asthma biomarkers are measurable signals in your blood that mirror the inflammation inside your airways. Blood testing highlights the immune pathways that tighten and swell the bronchial tubes, helping distinguish asthma driven by allergy-type inflammation from other patterns. Key players include eosinophils (a type of white blood cell) and allergic antibodies (IgE), which rise when type 2 immune responses are active (T2 inflammation). These arise from immune cells and the airway lining and reflect the release of inflammatory messengers (cytokines such as IL‑5 and IL‑13) that promote mucus production, airway sensitivity, and flare‑ups. Additional blood proteins from the airway-epithelial response (periostin) can also signal this biology. By capturing this internal story, biomarkers make invisible airway inflammation visible—showing how “hot” the disease is, how likely symptoms or exacerbations are, and which biologic targets may be relevant. In short, asthma biomarkers translate complex airway immune activity into objective clues your clinician can use to characterize the disease and personalize care.

Why eosinophils and CRP help phenotype asthma

Asthma blood biomarkers are signals from the immune and inflammatory systems that reveal how “hot” the airways and the whole body are. They help distinguish allergic, type 2–driven asthma from irritant- or infection-predominant patterns, anticipate flares, and show how much inflammation spills beyond the lungs into metabolism and the cardiovascular system. Two common labs matter here. Eosinophils, the allergy‑linked white cells, typically sit in the low single‑digit percent range (about 1–4%) or with absolute counts below about 0.5. CRP, a marker of whole‑body inflammation, is usually below about 3, and is healthiest toward the low end. When eosinophils rise, it points to type 2 airway inflammation, mucus overproduction, and a higher chance of wheeze, nighttime symptoms, and sinus/eczema clustering. Higher CRP suggests broader inflammatory stress—from an exacerbation, infection, obesity, or comorbid disease—and may come with fatigue, malaise, and greater cardiometabolic strain. When these values are low, they often reflect quiet airway biology. Low eosinophils indicate little allergic (eosinophilic) activity; symptoms, if present, may be cough and chest tightness with irritants, cold air, or viruses rather than classic allergy triggers. Low CRP supports a low systemic inflammatory load. Children with allergic tendencies more often show higher eosinophils; in pregnancy, CRP can run modestly higher even without infection. Big picture, these biomarkers connect the lungs to immune, metabolic, and vascular networks. Tracking them over time helps clarify asthma phenotype, risks for exacerbations and airway remodeling, and how much the condition interacts with sinus disease, atopic skin issues, weight, and long‑term heart and lung health.

Test 150+ biomarkers

Two blood draws. A full picture of your health, explained in plain language.

Book your test

Test 150+ biomarkers

Two blood draws. A full picture of your health, explained in plain language.

Book your test

What these markers add to an asthma picture

Asthma blood testing provides insight into how your immune system is functioning and how it may be influencing your overall health. Asthma is not just a lung condition—it’s a reflection of how your body manages inflammation and immune responses, which can affect energy, metabolism, cardiovascular health, and even cognitive function. At Superpower, we focus on two key biomarkers for asthma: Eosinophils and C-reactive protein (CRP).Eosinophils are a type of white blood cell involved in allergic reactions and defense against certain infections. In asthma, eosinophils can become elevated, signaling that the immune system is reacting strongly—sometimes too strongly—to environmental triggers. CRP is a protein produced by the liver in response to inflammation anywhere in the body. While CRP is not specific to asthma, higher levels can indicate ongoing inflammation, which is often present during asthma flare-ups or poorly controlled disease. Healthy levels of eosinophils suggest that the immune system is balanced and not overreacting, which supports stable airway function and reduces the risk of asthma symptoms. Similarly, a low CRP level indicates minimal systemic inflammation, which is associated with better respiratory health and overall stability. Together, these markers help reveal whether the body’s inflammatory and immune responses are under control, which is essential for maintaining healthy lung function in asthma. Interpretation of these biomarkers can be influenced by factors such as recent infections, allergies, age, pregnancy, and certain medications like steroids. Laboratory methods and reference ranges may also vary, so results are best understood in the context of your overall health and medical history.

Frequently Asked Questions

Asthma blood testing looks for signals of airway and systemic inflammation in your blood. Superpower measures eosinophils (a white blood cell linked to allergic/type 2 airway inflammation) and C‑reactive protein, or CRP (a marker of whole‑body inflammation). These markers don’t diagnose asthma by themselves; they help characterize your asthma phenotype, gauge inflammation burden, and track response to therapy alongside symptoms and lung function.

Corticosteroids and biologics that target type 2 pathways lower eosinophils. Allergen exposure, parasitic infection, and active asthma flares raise eosinophils. CRP rises with infection, obesity, smoking, autoimmune disease, and recent injury or surgery. Intense exercise, acute stress, and time of day cause modest shifts. A single abnormal value may reflect an intercurrent illness rather than asthma activity.

Blood eosinophils are typically below about 500 cells/µL. Levels above ~150 suggest type 2 inflammation; above ~300 often signal higher exacerbation risk and potential responsiveness to anti‑eosinophilic therapies. CRP is usually low (<3 mg/L) when systemic inflammation is minimal; marked elevations often reflect infection or another inflammatory trigger. These tests support, but do not replace, symptom history and lung function in diagnosing and managing asthma.